146 related articles for article (PubMed ID: 30039286)
1. Prognostic Value of Trefoil Factor 3 Expression in Patients with Gastric Cancer.
Taniguchi Y; Kurokawa Y; Takahashi T; Mikami J; Miyazaki Y; Tanaka K; Makino T; Yamasaki M; Nakajima K; Mori M; Doki Y
World J Surg; 2018 Dec; 42(12):3997-4004. PubMed ID: 30039286
[TBL] [Abstract][Full Text] [Related]
2. Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.
Dhar DK; Wang TC; Tabara H; Tonomoto Y; Maruyama R; Tachibana M; Kubota H; Nagasue N
Clin Cancer Res; 2005 Sep; 11(18):6472-8. PubMed ID: 16166422
[TBL] [Abstract][Full Text] [Related]
3. Impact of NPM, TFF3 and TACC1 on the prognosis of patients with primary gastric cancer.
Ding A; Zhao W; Shi X; Yao R; Zhou F; Yue L; Liu S; Qiu W
PLoS One; 2013; 8(12):e82136. PubMed ID: 24358147
[TBL] [Abstract][Full Text] [Related]
4. Significance of TFF3 protein and Her-2/neu status in patients with gastric adenocarcinoma.
Xu CC; Yue L; Wei HJ; Zhao WW; Sui AH; Wang XM; Qiu WS
Pathol Res Pract; 2013 Aug; 209(8):479-85. PubMed ID: 23822993
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of TFF1 and increased expression of TFF3 in gastric cancer: correlation with clinicopathological parameters and prognosis.
Im S; Yoo C; Jung JH; Choi HJ; Yoo J; Kang CS
Int J Med Sci; 2013; 10(2):133-40. PubMed ID: 23329884
[TBL] [Abstract][Full Text] [Related]
6. Comparison of serum trefoil factor 3 with the pepsinogen test for the screening of diffuse-type gastric cancer.
Lee JY; Park KS; Lee HG; Baek WK; Cho KB; Lee YJ; Lee YS; Ryu SW
Clin Exp Med; 2017 Aug; 17(3):403-410. PubMed ID: 27154568
[TBL] [Abstract][Full Text] [Related]
7. The value of trefoil factor 3 expression in predicting the long‑term outcome and early recurrence of colorectal cancer.
Morito K; Nakamura J; Kitajima Y; Kai K; Tanaka T; Kubo H; Miyake S; Noshiro H
Int J Oncol; 2015 Feb; 46(2):563-8. PubMed ID: 25405728
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
[TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of prognostic nutritional index in patients with advanced gastric cancer].
Song S; Liu H; Xue Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):180-184. PubMed ID: 29492917
[TBL] [Abstract][Full Text] [Related]
10. TFF3 and survivin expressions associate with a lower survival rate in gastric cancer.
Meng JR; Tang HZ; Zhou KZ; Shen WH; Guo HY
Clin Exp Med; 2013 Nov; 13(4):297-303. PubMed ID: 22996285
[TBL] [Abstract][Full Text] [Related]
11. Expression of trefoil factors and TWIST1 in colorectal cancer and their correlation with metastatic potential and prognosis.
Yusup A; Huji B; Fang C; Wang F; Dadihan T; Wang HJ; Upur H
World J Gastroenterol; 2017 Jan; 23(1):110-120. PubMed ID: 28104986
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic and clinicopathological value of trefoil factor 3 in patients with gastric cancer: a systematic review and meta-analysis.
Zhang CX; Wu CT; Xiao L; Tang SH
Biomarkers; 2021 Mar; 26(2):95-102. PubMed ID: 33401971
[TBL] [Abstract][Full Text] [Related]
13. CXCL1 gene silencing inhibits HGC803 cell migration and invasion and acts as an independent prognostic factor for poor survival in gastric cancer.
Wang L; Zhang C; Xu J; Wu H; Peng J; Cai S; He Y
Mol Med Rep; 2016 Nov; 14(5):4673-4679. PubMed ID: 27748927
[TBL] [Abstract][Full Text] [Related]
14. [Effect of lymphatic vascular invasion on the prognosis of stage I( gastric cancer patients after radical gastrectomy].
Shang L; Li B; He F; Li Y; Li J; Zhao Q; Li M
Zhonghua Wei Chang Wai Ke Za Zhi; 2018 Feb; 21(2):175-179. PubMed ID: 29492916
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of orphan nuclear receptor Nurr1 expression in gastric cancer.
Guo J; Zu G; Zhou T; Xing J; Wang Z
Clin Transl Oncol; 2015 Oct; 17(10):788-94. PubMed ID: 26022133
[TBL] [Abstract][Full Text] [Related]
16. Expression of trefoil peptides (TFF1, TFF2, and TFF3) in gastric carcinomas, intestinal metaplasia, and non-neoplastic gastric tissues.
Leung WK; Yu J; Chan FK; To KF; Chan MW; Ebert MP; Ng EK; Chung SC; Malfertheiner P; Sung JJ
J Pathol; 2002 Aug; 197(5):582-8. PubMed ID: 12210076
[TBL] [Abstract][Full Text] [Related]
17. Expression of trefoil factor 3 is decreased in colorectal cancer.
Espinoza I; Agarwal S; Reddy A; Shenoy V; Subramony C; Sakiyama M; Fair L; Poosarla T; Zhou X; Shannon Orr W; Lahr C; Bae S; Al Diffalha S; Manne U; Gomez CR
Oncol Rep; 2021 Jan; 45(1):254-264. PubMed ID: 33210724
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of ADAM17 expression in patients with gastric cancer who underwent curative gastrectomy.
Aydin D; Bilici A; Yavuzer D; Kefeli U; Tan A; Ercelep O; Mert A; Yuksel S; Ozcelik M; Isik D; Surmeli H; Odabasi H; Aliustaoglu M
Clin Transl Oncol; 2015 Aug; 17(8):604-11. PubMed ID: 25786367
[TBL] [Abstract][Full Text] [Related]
19. Low junctional adhesion molecule A expression correlates with poor prognosis in gastric cancer.
Huang JY; Xu YY; Sun Z; Wang ZN; Zhu Z; Song YX; Luo Y; Zhang X; Xu HM
J Surg Res; 2014 Dec; 192(2):494-502. PubMed ID: 25033702
[TBL] [Abstract][Full Text] [Related]
20. An abnormally high expression of ISL-1 represents a potential prognostic factor in gastric cancer.
Guo C; Wang W; Shi Q; Chen P; Zhou C
Hum Pathol; 2015 Sep; 46(9):1282-9. PubMed ID: 26142548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
